May 9, 2018 / 8:37 PM / 6 months ago

BRIEF-VTV Therapeutics Announces Company Will Pre-Specify New Subgroup With The FDA

May 9 (Reuters) - vTv Therapeutics Inc:

* VTV THERAPEUTICS ANNOUNCES COMPANY WILL PRE-SPECIFY NEW SUBGROUP WITH THE FDA AND REPORT PHASE 3 PART B RESULTS IN JUNE

* VTV THERAPEUTICS INC - SUBGROUP OF MILD ALZHEIMER’S PATIENTS IN PART A OF PHASE 3 STEADFAST STUDY DEMONSTRATED POSITIVE BENEFIT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below